Playing cancer at its own game: activating mitogenic signaling as a paradoxical intervention

Matheus Henrique Dias1, René Bernards1

  • 1Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Molecular Oncology
|May 6, 2021
PubMed

Insights

This study proposes a paradoxical cancer therapy approach. Instead of inhibiting cancer growth, it suggests activating signaling pathways to overload cancer cells, potentially leading to their death.

Area of Science:

  • Oncology
  • Cancer Biology
  • Pharmacology

Background:

  • Conventional cancer therapies face challenges with resistance and modest benefits in advanced stages.
  • Paradoxical interventions in psychotherapy reinforce pathological behaviors to improve conditions.
  • Targeted cancer therapies inhibit oncogenic signaling but often encounter resistance.

Purpose of the Study:

  • To explore a 'paradoxical intervention' strategy for cancer therapy.
  • To propose activating mitogenic signaling rather than inhibiting it.
  • To discuss how this approach could overcome current cancer treatment challenges.

Main Methods:

  • Reviewing the concept of paradoxical interventions.
  • Analyzing the potential of overactivating mitogenic signaling in cancer cells.
  • Considering combination therapy with stress-targeted drugs.

Main Results:

  • The proposed therapy aims to disrupt cancer cell homeostasis and overload stress response pathways.
  • Overactivation of signaling could lead to cancer cell death.
  • This approach leverages differences between normal and cancer cells.

Conclusions:

  • A paradoxical approach of activating oncogenic signaling offers a novel strategy for cancer therapy.
  • This unconventional method may provide a new avenue to combat advanced cancers and resistance.
  • Further research is needed to explore the clinical applicability of paradoxical cancer interventions.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.6K